Clinical trial
Photodynamic Therapy for the Prevention of Lung Cancer (PEARL)
NCT03346304 is registered in ClinicalTrials.gov with University College, London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Photodynamic Therapy for the Prevention of Lung Cancer (PEARL)
- Lead sponsor
- University College, London
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- September 30, 2018
- Completion date
- October 31, 2024
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, squamous cell lung cancer